News

Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know
Novo Nordisk (NVO) closed the most recent trading day at $65.29, moving 2.61% from the previous trading session.
Hims & Hers Health, Inc. (HIMS) Alleged“Deceptive” Marketing Of Wegovy® Triggers Securities Class Actions HIMS Investors With Losses Encouraged To Contact Hagens Berman
National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...
Drugmaker-telehealth deals risk unnecessary prescribing, senators’ probe finds
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Nvidia, Google, Tesla shares among top US stocks bought by Indian investors in Q1FY26
Indian retail investors ramped up US stock purchases amid global market volatility, with a strong tilt toward semiconductors, ...
Zacks Investment Research on MSN10h
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...
USA Herald14h
Hims & Hers Executives Face Lawsuit Over Knockoff Wegovy Sales
Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...
Novo Nordisk Owner Buys Microsoft Quantum Computer With Denmark
The foundation behind Novo Nordisk A/S and the Danish government will invest €80 million ($93 million) in a Microsoft-powered ...